Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-20T07:00:24.007Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessment and Diagnosis of Excessive Daytime Sleepiness

Published online by Cambridge University Press:  07 November 2014

Richard K. Bogan
Get access Rights & Permissions [Opens in a new window]

Extract

The symptoms of excessive daytime sleepiness (EDS) need to be assessed both clinically and with objective diagnostics. As with any other medical disorder, when patients present with excessive sleepiness, the first step is to determine the chief complaint. The spectrum of clinical presentations for EDS is wide, and patients may complain of fatigue, low energy, laziness, apathy, lethargy, poor memory, reduced concentration, reduced attention, irritability, poor performance in work/school, automatic behavior, frequent accidents, drowsiness, and/or sleep attacks. Oftentimes patients do not recognize their own excessive sleepiness and will not quantify the problem unless they are specifically asked if they are sleepy. Some of these patients only present because they have been referred by their employers due to their excessive sleepiness.

After the patient has noted his chief complaint, the clinician should assess the patient's score on the Epworth Sleeping Scale (ESS) on a quantifiable basis. The ESS is a self-administered questionnaire used to rate the severity of EDS. Respondents are asked to use a numeric scale from 0 to 3, corresponding to the likelihood (never, slight, moderate, and high) that they may fall asleep in eight given situations (Slide 1). An ESS score can range from 0 to 24. A score >9 indicates an abnormal level of sleepiness. A score >14 suggests marked sleepiness. Most patients with narcolepsy will score in this range. The normal range varies for different sleep disorders (Slide 2).

Type
Research Article
Information
CNS Spectrums , Volume 12 , supplement S2: Recent Advances in the Treatment and Management of Excessive Daytime Sleepiness , February 2007 , pp. 7 - 9
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Overeem, S, Mignot, E, van Dijk, JG, Lammers, GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol. 2001:18(2):78–105.CrossRefGoogle ScholarPubMed
2.Bassetti, C, Aldrich, MS. Narcolepsy. Neurol Clin. 1996;14(3):545–571.CrossRefGoogle ScholarPubMed
3.Black, JE, Brooks, SN. Narcolepsy: evaluation and management. CNS News Special Edition. 2005.Google Scholar
4.Ruggles, K, Hausman, N. Evaluation of excessive daytime sleepiness. WMJ. 2003;102:21–24.Google ScholarPubMed
5.Johns, MW, A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14(6):540–545.CrossRefGoogle ScholarPubMed
6.Thorpy, MJ. Classification of sleep disorders. J Clin Neurophysiol. 1990;7(1):67–81.CrossRefGoogle ScholarPubMed
7.Thorpy, MJ. Sleep disorders: simple or complex? Hosp Pract (Off Ed). 1994;29(9):39–45.CrossRefGoogle ScholarPubMed
8.Guilieminault, C, Brooks, N. Excessive daytime sleepiness: a challenge for the practicing neurologist. Brain. 2001;124 (Pt 8):1482–1491.CrossRefGoogle Scholar
9.Ohayon, MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111.CrossRefGoogle ScholarPubMed
10.Bixler, EO, Vgontzas, AN, Ten Have, T, Tyson, K, Kales, A. Effects of age on sleep apnea In men: I. Prevalence and severity. Am J Pespir Crit Care Med. 1998:157(1):144–148.CrossRefGoogle ScholarPubMed
11.Hening, W, Walters, AS, Allen, RP, Montplaisir, J, Myers, A, Ferini-Strambi, L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237–246.CrossRefGoogle Scholar
12.Ohayon, MM, Priest, RG, Zulley, J, et al.Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology. 2002;58:1826–1833.CrossRefGoogle ScholarPubMed
13.Punjabi, NM, Welch, D, Strohl, K. Sleep disorders in regional sleep centers: a national cooperative study. Coleman II Study Investigators. Sleep. 2000;23(4):471–480.CrossRefGoogle Scholar
14.Carskadon, MA, Dement, WC, Mitler, MM, Roth, T, Westbrook, PR, Keenan, S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986;9(4):519–524.CrossRefGoogle ScholarPubMed
15.Carskadon, MA, Dement, WC, Mitler, MM, Guilieminault, C, Zarcone, VP, Spiegel, R. Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry. 1976;133:1382–1388.Google ScholarPubMed
16.Olson, LG, Cole, MF, Ambrogettl, A. Correlations among Epworth Sleepiness Scale scores, multiple sleep latency tests and psychological symptoms. J Sleep Pes. 1998; 7(4):248–253.CrossRefGoogle ScholarPubMed
17.Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multlcenter Study Group. Ann Neurol 1998;43(1):88–97.CrossRefGoogle Scholar
18.Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Gioup. Neurology 2000;54(5):1166–1175.CrossRefGoogle Scholar
19.Mitler, MM, Gujavarty, KS, Browman, CP. Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol. 1982;53(6):658–661.CrossRefGoogle Scholar